Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancerShanna A. Arnold Egloff, Andries Zijlstra|Oncotarget|2016Cited by 24
Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysisKatie E. Hebron, Andries Zijlstra, Shanna A. Arnold Egloff et al.|Scientific Reports|2018Cited by 18